The historic rise of Viagra has firmly established as a symbol of pharmaceutical success, but its legacy within the broader sector now triggers questions about potential gains. Alternative versions are eroding patent protection , leading to worries that betting on companies significantly dependent to Viagra's former influence could be a problematic